Denis Bruniquel

Title: Innovations of Denis Bruniquel

Introduction

Denis Bruniquel is a notable inventor based in Thoiry, France. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that target specific interleukins. With a total of three patents to his name, Bruniquel's work is paving the way for advancements in medical treatments.

Latest Patents

Bruniquel's latest patents focus on polypeptides that bind to IL-17A, IL-17F, and/or IL-17A/F. These patents describe amino acid sequences that are directed against these interleukins, including combinations thereof. The compounds and constructs developed by Bruniquel, particularly proteins and polypeptides, are designed to comprise or essentially consist of one or more such amino acid sequences. This innovative approach has the potential to lead to new methods of treatment for various conditions.

Career Highlights

Denis Bruniquel is currently associated with Merck Patent GmbH, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, contributing to the understanding of immune responses and therapeutic interventions.

Collaborations

Bruniquel collaborates with esteemed colleagues such as Heidi Rommelaere and Joost Alexander Kolkman. These partnerships enhance the scope and impact of his research, fostering innovation in the field.

Conclusion

Denis Bruniquel's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the industry. His work on polypeptides targeting IL-17A and related interleukins represents a significant advancement in medical science.